Alpha 2.0
Login Register
» Authors » Fu-Lun Chen

Fu-Lun Chen

Explore the profile of Fu-Lun Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 318
Followers 0
Related Specialties
Microbiology
Allergy & Immunology
Infectious Diseases
Top 10 Co-Authors
Wen-Sen Lee
Tsong-Yih Ou
Shio-Shin Jean
Tai-Chin Hsieh
Po-Ren Hsueh
Cheng-Hui Wang
Fang-Lan Yu
Yu-Cheng Hsiao
Sing-On Teng
Chin-Wang Hsu
Published In
J Microbiol Immunol Infect
Polymers (Basel)
Medicine (Baltimore)
J Infect
Biomed Opt Express
Affiliations
Soon will be listed here.
Recent Articles
21.
Breakthrough fungemia caused by Rhodotorula mucilaginosa during anidulafungin therapy
Wang C, Hsueh P, Chen F, Lee W
J Microbiol Immunol Infect . 2018 Feb; 52(4):674-675. PMID: 29429866
No abstract available.
22.
Community-acquired bacteremic pneumonia due to Pasteurella multocida subspecies multocida in a patient with poor-control diabetes mellitus
Lee W, Chen F, Wang C, Ou T, Lin Y, Jean S
J Microbiol Immunol Infect . 2018 Jan; 52(1):163-164. PMID: 29289552
No abstract available.
23.
Pulmonary empyema caused by co-infections of Mycoplasma pneumoniae and Fusobacterium necrophorum: A rare case of lemierre syndrome
Chen F, Jean S, Ou T, Yu F, Lee W
J Microbiol Immunol Infect . 2017 Jul; 50(4):552-554. PMID: 28698043
No abstract available.
24.
Streptococcus sanguis bacteremia complicating endocarditis associated with colonic adenocarcinoma
Chen F, Jean S, Ou T, Wang G, Yu F, Lee W
J Microbiol Immunol Infect . 2017 Jul; 50(3):399-400. PMID: 28698041
No abstract available.
25.
Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
Wu U, Hsieh S, Lee W, Wang N, Kung H, Ou T, et al.
Vaccine . 2017 Jul; 35(33):4099-4104. PMID: 28668573
Background: We conducted a phase I/II clinical trial to evaluate the safety and immunogenicity of a Madin-Darby canine kidney (MDCK) cell-grown inactivated H7N9 influenza vaccine for pandemic preparedness purposes. Methods:...
26.
Corrigendum to "Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia" [J Microbiol Immunol Infect (2016)] pii: S1684-1182(16)30029-9. [Epub ahead of print]
Lee W, Hsueh P, Hsieh T, Chen F, Ou T, Jean S
J Microbiol Immunol Infect . 2017 Feb; 52(3):510. PMID: 28185780
No abstract available.
27.
Carbapenem-resistant Acinetobacter baumannii mediastinitis after aortic graft implantation successfully treated by adjunctive gentian violet irrigation and antibiotic combination therapy
Li S, Chang C, Chen F, Ou T, Lee W
J Microbiol Immunol Infect . 2016 Aug; 49(6):977-979. PMID: 27553449
No abstract available.
28.
Bio-Kil, a nano-based disinfectant, reduces environmental bacterial burden and multidrug-resistant organisms in intensive care units
Lee W, Hsieh T, Shiau J, Ou T, Chen F, Liu Y, et al.
J Microbiol Immunol Infect . 2016 Jun; 50(5):737-746. PMID: 27262208
Background/purpose: This prospective before-after study was intended to investigate the effect of Bio-Kil on reducing environmental bacterial burden and healthcare-associated infections (HAIs) in intensive care units (ICUs) at the Municipal...
29.
Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia
Lee W, Hsueh P, Hsieh T, Chen F, Ou T, Jean S
J Microbiol Immunol Infect . 2016 Apr; 50(4):547-548. PMID: 27094385
No abstract available.
30.
Co-occurrence of Leriche syndrome and antiphospholipid syndrome in a man with refractory ulcers of the lower limbs
Hsieh T, Hsueh P, Yu F, Jean S, Chen F, Ou T, et al.
J Microbiol Immunol Infect . 2015 Dec; 49(2):309-10. PMID: 26712093
No abstract available.